Verition Fund Management’s Celularity Inc CELUW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-15,000
Closed -$6K 2212
2022
Q3
$6K Hold
15,000
﹤0.01% 2925
2022
Q2
$51K Hold
15,000
﹤0.01% 2144
2022
Q1
$21K Hold
15,000
﹤0.01% 2600
2021
Q4
$12K Hold
15,000
﹤0.01% 2485
2021
Q3
$17K Hold
15,000
﹤0.01% 1831
2021
Q2
$20K Hold
15,000
﹤0.01% 1837
2021
Q1
$17K Hold
15,000
﹤0.01% 1504
2020
Q4
$43K Hold
15,000
﹤0.01% 1045
2020
Q3
$24K Buy
+15,000
New +$22.6K ﹤0.01% 1018

Other funds holding CELUW

Verition Fund Management's CELUW Position: Q4 2022 in Review

Verition Fund Management sold out of Celularity Inc (CELUW) in Q4 2022, closing a stake of 15,000 shares — an estimated $6K sold.

Verition Fund Management first reported a position in CELUW in Q3 2020 and held it in 9 quarters. The position peaked at $51K in Q2 2022. 20 funds tracked by Wall St. Rank hold CELUW as of Q4 2022.

  • Verition Fund Management reported no remaining Celularity Inc position as of Q4 2022 after selling out during the quarter.
  • Verition Fund Management sold 15,000 Celularity Inc shares in Q4 2022, an estimated $6K.
  • Verition Fund Management first reported a position in Celularity Inc in Q3 2020 and held it in 9 quarters.
  • Verition Fund Management's Celularity Inc position peaked at $51K in Q2 2022.
  • 20 funds tracked by Wall St. Rank held Celularity Inc as of Q4 2022.

Based on Verition Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.